Psychosocial Impact of Alternative Management Policies for Low-Grade Cervical Abnormalities: Results from the TOMBOLA Randomised Controlled Trial-Reference-Cited by-同舟云学术

Psychosocial Impact of Alternative Management Policies for Low-Grade Cervical Abnormalities: Results from the TOMBOLA Randomised Controlled Trial

Published:2013-12-30 Issue:12 Volume:8 Page:e80092
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Sharp Linda,Cotton Seonaidh,Little Julian,Gray Nicola M.,Cruickshank Margaret,Smart Louise,Thornton Alison,Waugh Norman,Walker Leslie,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference54 articles.

1. Raffle AE, Gray JAM (2007) Screening. evidence and practice. Oxford: Oxford University Press.

2. International Agency for Research on Cancer (2005) Cervical cancer screening: IARC handbooks of cancer prevention. Lyon: IARC Press.

3. Cervical Screening Wales (2010) KC53/61/65 statistical report – adroddiad ystadegol 2009/10. 2010.

4. ISD Scotland (2010) Annual workload data. Up to 31^st March 2010. 12/14.

5. NHS National Statistics. Health and Social Care Information Centre. Public Health Indicators and Population Statistics Team. (2010) Cervical screening programme. England. 2009–10. 2010.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Artificial Neural Network Prediction Model of Depressive Symptoms among Women with Abnormal Papanicolaou Smear Results before and after Diagnostic Procedures;Life;2024-09-07

2. Molecular Classification of Endometrial Cancer and the 2023 FIGO Staging: Exploring the Challenges and Opportunities for Pathologists;Cancers;2023-08-15

3. A Systematic Review of Population-Based Studies of Chronic Bowel Symptoms in Cancer Survivors following Pelvic Radiotherapy;Cancers;2023-08-09

4. Psychological Distress in Women With Abnormal Pap Smear Results Attending Cervical Cancer Screening;Journal of Lower Genital Tract Disease;2023-08-03

5. Preinvasive disease of the cervix;DiSaia and Creasman Clinical Gynecologic Oncology;2023